The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis
Journal of Integrative Neuroscience · 2024
DOI: 10.31083/j.jin2305100 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Journal of Integrative Neuroscience, 2024. Verfasst von Lucio De Maria und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Neurosurgery, Department of Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25123 Brescia, Italy. Hauptthemen laut MEDLINE: Glioma, Magnetic Resonance Imaging, Brain Neoplasms, Neoplasm Grading. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Multiple radiomics models have been proposed for grading glioma using different algorithms, features, and sequences of magnetic resonance imaging. The research seeks to assess the present overall performance of radiomics for grading glioma.
Methods
A systematic literature review of the databases Ovid MEDLINE PubMed, and Ovid EMBASE for publications published on radiomics for glioma grading between 2012 and 2023 was performed. The systematic review was carried out following the criteria of Preferred Reporting Items for Systematic Reviews and Meta-Analysis.
Results
In the meta-analysis, a total of 7654 patients from 40 articles, were assessed. R-package mada was used for modeling the joint estimates of specificity (SPE) and sensitivity (SEN). Pooled event rates across studies were performed with a random-effects meta-analysis. The heterogeneity of SPE and SEN were based on the χ2 test. Overall values for SPE and SEN in the differentiation between high-grade gliomas (HGGs) and low-grade gliomas (LGGs) were 84% and 91%, respectively. With regards to the discrimination between World Health Organization (WHO) grade 4 and WHO grade 3, the overall SPE was 81% and the SEN was 89%. The modern non-linear classifiers showed a better trend, whereas textural features tend to be the best-performing (29%) and the most used.
Conclusions
Our findings confirm that present radiomics’ diagnostic performance for glioma grading is superior in terms of SEN and SPE for the HGGs vs. LGGs discrimination task when compared to the WHO grade 4 vs. 3 task.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Neurosurgery, Department of Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, 25123 Brescia, Italy.
- Interuniversity Department of Regional and Urban Studies and Planning, Politecnico di Torino, 10125 Torino, Italy.
- Department of Medical Artificial Intelligence, Konyang University, 35365 Daejeon, Republic of Korea.
- Department of Radiology and Nuclear Medicine, University of Oslo, 0372 Oslo, Norway.
- Department of Medical Physics, University of Thessaly, 413 34 Larissa, Greece.
- Department of Mathematical Sciences "Giuseppe Luigi Lagrange", Politecnico di Torino, 10123 Torino, Italy.
Zitieren
APA
De Maria, L., Ponzio, F., Cho, H. H., Skogen, K., Tsougos, I., Gasparini, M., Zeppieri, M., Ius, T., Ugga, L., Panciani, P. P., Fontanella, M. M., Brinjikji, W., & Agosti, E. (2024). The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis. Journal of Integrative Neuroscience. https://doi.org/10.31083/j.jin2305100
Vancouver
De Maria L, Ponzio F, Cho HH, Skogen K, Tsougos I, Gasparini M, et al. The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis. Journal of Integrative Neuroscience. 2024. doi:10.31083/j.jin2305100
BibTeX
@article{DeMaria2024,
author = {De Maria, Lucio and Ponzio, Francesco and Cho, Hwan-Ho and Skogen, Karoline and Tsougos, Ioannis and Gasparini, Mauro and Zeppieri, Marco and Ius, Tamara and Ugga, Lorenzo and Panciani, Pier Paolo and Fontanella, Marco Maria and Brinjikji, Waleed and Agosti, Edoardo},
title = {The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis},
journal = {Journal of Integrative Neuroscience},
year = {2024},
doi = {10.31083/j.jin2305100}
}
EUVIMED